Abstract:Key PointsMicroRNAs (miRNAs) located in genomic regions amplified in cancers (such as the miR-17–92 cluster) function as oncogenes, whereas miRNAs located in portions of chromosomes deleted in cancers (such as the miR-15a–miR-16-1 cluster) function as tumour suppressors.Abnormal expression of miRNAs has been found in both solid and haematopoietic tumours by various genome-wide techniques (including different microarray platforms or bead-based flow cytometry).The abnormally expressed miRNAs in human cancers target transcripts of essential protein-coding genes involved in tumorigenesis, such as the Ras oncogenes by let-7 family members, the BCL2 anti-apoptotic gene by the miR-15a–miR-16-1 cluster, the E2F1 transcription factor by the miR-17–92 cluster or the BCL6 anti-apoptotic gene by miR-127.MiRNA expression fingerprints correlate with clinical and biological characteristics of tumours, including tissue type, differentiation, aggression and response to therapy.The fact that consistent abnormal expression of the precursor miRNA, but not of the correspondent active molecule, is found in various types of cancers, raises the possibility that the 'non-active' part of the miRNA molecule could have 'independent' and as yet unknown functions that could be important in tumorigenesis.Germline sequence abnormalities were identified in miRNA genes and transcripts, and in targeted sequences in messenger RNAs that are known to be targets of miRNAs. Furthermore, as each miRNA has many targets, inherited minor variations in miRNA expression could have important consequences for the expression of various protein-coding genes involved in malignant transformation. Therefore, it is tempting to propose that both these phenomenons are involved in familial predisposition to cancer.

Causes and consequences of microRNA dysregulation in cancer

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

How MicroRNAs Command the Battle against Cancer

Mechanisms of Microrna Deregulation in Human Cancer

MicroRNA signatures in human cancers

MicroRNAs As Potential Biomarkers in Cancer: Opportunities and Challenges

MicroRNA-183 in Cancer Progression

The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer

A microRNA polycistron as a potential human oncogene

Regulatory Mechanism of MicroRNA Expression in Cancer

Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development

MicroRNA and Human Cancer

Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications

MicroRNA regulatory network and cancer

MicroRNA biogenesis pathways in cancer

MicroRNAs and Cancer: Key Paradigms in Molecular Therapy (Review)

Exploiting the therapeutic potential of microRNAs in human cancer

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

MicroRNAs and the hallmarks of cancer

MicroRNA expression profiles classify human cancers

Crosstalk between miRNAs and DNA Methylation in Cancer